Zocdoc, which pivoted from patient scheduling to offering telehealth services during the pandemic, raises a $150M growth round from Francisco Partners
Context & Ripple Effects
Zocdoc's $150M growth round lands in the middle of a pandemic-era funding run through digital health: telemedicine demand pulled capital into Medici's $24M Series B, Tyto Care's $50M round, and later Pager's $70M Series C and Solv's $45M Series C. The difference is that Zocdoc arrived at telehealth sideways — it built its business on patient scheduling before adding virtual visits when COVID-19 hit.
First-order effects
- Zocdoc gains a large growth check to scale its post-pivot telehealth offering, while Francisco Partners adds another healthcare-technology asset to an active buying streak that includes Weave Communications, Moneris, and Jama Software.
Second-order effects
- Solv's same-day appointment software and DocPlanner's international booking platform now compete against a better-capitalized Zocdoc that spans both scheduling and virtual care, pressuring them to raise or differentiate on price and provider coverage.
Third-order effects
- If the pattern holds, patient access consolidates around scaled platforms that bundle booking with care delivery, with private equity firms like Francisco Partners acting as the consolidators rather than traditional strategic acquirers.
The trend: Digital health is consolidating around full-stack patient-access platforms funded by private equity, as pandemic-era telehealth adoption turns scheduling software companies into care-delivery businesses.